Building a Library of Difluoromethyl- and Trifluoromethyl-Artemisinins: Year Two
CSEF · 2014 Chemistry Fourth Award
Overview
Objectives/Goals In recent years fluorine has become increasingly important to the pharmaceutical industry. Coupled with already-potent drugs, fluorine has allowed common therapies to become even more effective in treating many diseases. One disease that could particularly benefit from the development of a more effective treatment method is malaria. For centuries malaria has been treated with artemisinin, but drug resistance has drastically reduced the effectiveness. Recognizing the benefits of adding fluorine to pharmaceuticals, this study focused on developing the methodology required to successfully incorporate fluorine into molecules of biological importance. Methods/Materials In order to improve bioavailability of artemisinin, two types of fluroalkylation were experimented with. This study focused on successfully trifluoromethylating artemisinin before branching out into the more complex difluoromethylation process. The Ruppert- Prakash Reagent was used to trifluoromethylate artemisinin. The next phase of research consisted of developing a methodology for the difluoromethylation of artemisinin. Methyl- 4- nitrobenzoate was used as a surrogate molecule to model the behavior of artemisinin in the difluoromethylation process. The difluoromethylating reagents used were TMSCF(2)H and TMSCF(2)Br and activating agents were CsF and K(2)CO3. Results The goal of creating a trifluoroartemisinin analog was achieved, and the difluoromethylation procedures show great promise for further research. Low yields of product are indicative of the potential for a more successful methodology to be developed. Conclusions/Discussion This research successfully synthesized a trifluoromethyl-artemisinin analog, one of the primary goals set for this year of research. In addition, basic difluoromethylation displayed some positive results. Overall, this work has created the necessary platform to create even more analogs of artemisinin that can supplement the existing library of drugs yielding an opportunity for biological testing.
Summary statement
This project focused on fluoroalkylating artemisinin, an antimalarial drug, to increase its bioavailability and address the issue of drug resistance.
Help received
Worked at USC Loker Hydrocarbon Research Institute under the supervision of Dr. Surya Prakash.
Awards (1)
Competition history
- CSEF 2014
Resources
Related projects
ISEF · 2014
Building a Library of Difluoro- and Trifluoro- Artemisinins, Year Two
ISEF · 2015
Synthesizing and Utilizing Difluoromethyl- & Trifluoromethyl- Artemisinins to Interrupt the Life Cycle of Malaria Parasites, Year III
CSEF · 2013
Increasing the Bioefficacy of Artemisinin through Trifluoromethylation
ISEF · 2015
Nucleophilic Difluoromethylation of Arylidene Meldrum's Acid Derivatives
ISEF · 2014
Antimalarials: Modeling the Next Generation Inhibitors
CSEF · 2006
Identification of the Determinants of Antimalarial Drug Action
ISEF · 2024
Evaluation of Antimalarial Activity of Artemisinin Derivatives by the Reaction with Fe(II) Ion in Micelles
ISEF · 2021
Phase II: Towards the Total Synthesis of the Leishmanicidal Lindbergin E for the Development of an Enantioselective Phloroglucinol-Derived Polyketide Synthesis
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects